Observed Signal · Nov 16, 2026 · executive_change · Source: SEC API · Impact: 3/5
Oscar Appoints Three Independent Directors to Board, Expanding Size to Eleven
On November 12, 2026, the Board of Directors of Oscar Health, Inc. appointed Tomer Cohen, Eric Larsen, and Rajat Taneja as independent directors, effective November 13, 2026. In connection with these appointments, the Board expanded its total size from eight to eleven members. Each director will serve until the 2027 annual meeting of stockholders. Additionally, Mr. Cohen joined the Talent and Compensation Committee, while Mr. Taneja joined the Audit Committee and Nominating and Corporate Governance Committee. The newly appointed directors bring significant expertise across technology, consumer product scaling, enterprise security, healthcare advisory, and AI. They will receive standard non-employee director compensation comprising a $70,000 annual cash retainer, committee retainers ranging from $5,000 to $10,000, and initial and annual RSU grants valued at $200,000 each.
Expands board governance and technical acumen by adding senior technology and healthcare leaders (ex-LinkedIn CPO, Visa President of Technology, and TowerBrook Advisors President), enhancing strategic oversight for Oscar's tech platform and healthcare operations.
MARKET SIGNALS
Track Oscar Signals & Strategic Shifts
Polaris7 connects regulatory filings, primary sources, leadership changes, and M&A activity into structured intelligence. Set up your Polaris7 workspace to monitor relevant companies in your executive briefing.
- Verified primary sources
- Automated briefings
- Instant watchlist setup
Key Takeaways & Evidence Grounding
- Board expanded from eight to eleven members effective November 13, 2026, with the election of Tomer Cohen, Eric Larsen, and Rajat Taneja.
- Tomer Cohen was appointed to the Compensation Committee; Rajat Taneja was appointed to the Audit and NCG Committees.
- Director compensation includes a $70,000 annual cash retainer, committee retainers between $5,000 and $10,000, and $200,000 in initial and annual RSU awards.
Connected Companies & Entities
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
8-K Financial Filing Analysis for UiPath (2026-09-03)
UiPath, Inc. announced comprehensive executive leadership and governance updates effective September 3, 2026. Hitesh Ramani, previously Deputy CFO and Chief Accounting Officer, has been promoted to Chief Financial Officer, allowing Ashim Gupta to focus exclusively on his role as Chief Operating Officer. Concurrently, Brad Brubaker transitioned to Chief Legal & Administrative Officer, and the Board expanded to eight members with the appointment of Kaiser Permanente EVP Yazdi Bagli as an independent director. In addition, CEO Daniel Dines adopted a Rule 10b5-1 trading plan to sell up to 5,000,000 Class A common shares through February 1, 2027.
8-K Financial Filing Analysis for Okta (2026-09-18)
Okta, Inc. announced changes to its Board of Directors in a Form 8-K filing. Effective September 14, 2026, Emilie Choi resigned as a Class I director without any reported disagreements regarding company operations, policies, or practices. Subsequently, on September 17, 2026, the Board appointed Helen Riley as an independent Class I director and a member of the Audit Committee, effective September 18, 2026, with a term running until the 2027 Annual Meeting of Stockholders. Under Okta's standard non-employee director compensation arrangements, Riley will receive an annual board retainer of $35,000, an additional $13,000 for her Audit Committee service, and an initial grant of 2,907 restricted stock units vesting annually over three years.
Digimarc Enters Cooperation Agreement with Ocho Investments, Overhauling Board of Directors
On November 15, 2026, Digimarc Corporation entered into a Cooperation Agreement with Ocho Investments LLC, the beneficial owner of 5.0 million shares of common stock. Under the agreement, Digimarc expanded its Board of Directors from eight to eleven members, appointing Andris Upitis, Kevin McConnell, and Amy O'Keefe. Concurrently, four incumbent directors—Katie Kool, Sheila Cheston, Sandeep Dadlani, and LaShonda Anderson-Williams—tendered resignations effective December 31, 2026, which will reduce the board size to a capped maximum of nine directors. Ocho agreed to customary standstill, voting, and non-disparagement provisions through at least December 31, 2027. Additionally, CEO Paul Carreiro agreed to modify his compensation arrangements to waive change-of-control benefits triggered by the board reconstitution while lowering performance vesting stock price hurdles.
WATCHLIST & BRIEFINGS
Receive future signals for Oscar & competitors in your briefing
Stay ahead of material M&A deals, leadership changes, account wins, and product rollouts. Polaris7 connects primary filings, company newsrooms, and trade reporting directly into your executive briefing.
- Regular primary-source checks
- Structured Watchlist briefings
- Preserves current context
Market Signal Monitoring
Follow affected companies in Polaris7 with regular source checks and structured Watchlist briefings.
Monitor Oscar
Follow affected companies in Polaris7 with regular source checks and structured Watchlist briefings.
